Mandate

Vinge advises STMicroelectronics on its acquisition of a majority stake in Norstel AB

February 07, 2019 M&A

Vinge has advised the French-Italian electronics and semiconductor manufacturer STMicroelectronics in connection with STMicroelectronics entering into an agreement to acquire a majority stake in the Swedish silicon carbide wafer manufacturer Norstel AB.

Upon completion of the transaction (which is subject to conditions), STMicroelectronics will acquire 55% of Norstel AB, with an option to acquire the remaining 45% subject to certain conditions. If such option is exercised, it will result in a total consideration of USD 137,500,000 for 100% of Norstel AB.

Vinge’s team consisted of, among others, Christina Kokko, Ulrich Ziche, Linda Sengul and Desirée Sjöblom (Corporate and M&A), Gu Qun, Gabriella Fossum, Jasmin Draszka-Ali and Hayaat Ibrahim (Regulatory and Compliance), Klara Secher (IP), Sophia Holm and Lova Unge (Employment), Nicklas Thorgerzon (IT), Axel Jansson and Anna Åhlberg (Banking and Financing), Anne Wijkman (Real Estate/Lease Agreements), Trine Osen Bergkvist (Competition), Fredrika Hjelmberg (Commercial Agreements), Hampus Olsson (Environment) and Jessica Öijer (VDR assistant).
 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025